Skip to content

Whipple-Rheuma Study

Whipple-Rheuma Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015669
Enrollment
151
Registered
2018-11-13
Start date
2015-03-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K90.8 M05 M45 L40.5 M12.3

Interventions

Group 1: Rheumatic symptoms recorded 1) by patients with Whipple's disease on specific questionnaires are to be compared with 2) the response of patients with rheumatoid arthritis, psoriatic arthropat

Sponsors

DRK Krankenhaus Neuwied
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnostic criteria:; Whipple’s disease, [S2k Leitlinie Morbus Whipple, Z. Gastroenterol 2015;53:418] those with rheumatoid arthritis the 2010 American College of Rheumatology (ACR) and European League Against Rheumatism classification criteria, those with psoriasis arthritis – the CASPAR criteria, and the patients with axial spondyloarthritis – the ASAS classification criteria, Palindromic arthritis was diagnosed when episodic and saltatory arthritis with articular pain and swelling occurred in patients in the presence of either anti-citrullinated protein antibodies (ACPA) in 14 patients or isolated positive rheumatoid factor in one patient.

Exclusion criteria

Exclusion criteria: when no consent is given by the patient

Design outcomes

Primary

MeasureTime frame
All patients consenting and fulfilling the diagnostic criteria are asked to answer questionnaires as there were 40 patients with Whipple's disease, +20 patients with Whipple's disease as validation group + 30 patients with rheumatoid arthritis +25 patients with axial spondyloarthritis+ 21 patients with psoriatic arthritis + 15 patients with palindromic arthritis. Primary outcome measure is registration and evaluation of the clinical symptoms recorded in the questionnaires.

Secondary

MeasureTime frame
The questionnaire results studied with logistic regression analysis to check for clinical usefulness in the differential diagnosis were validated in an additional group of 20 patients with Whipple's disease

Countries

Germany

Contacts

Public ContactVerena Moos

Charité Universitätsmedizin Berlin, Campus Benjamin Franklin Medizinische Klinik 1

verena.moos@charite.de030 6149462

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026